Thanks @Stretguy. I've been holding for quite a while, so I...

Thanks @Stretguy. I've been holding for quite a while, so I am well versed in Steve's contributions.
So many of you bag this stock and it's current position on the timeline of the tech's development, yet I'd bet none of you have the experience of ever taking groundbreaking technology from concept to commercialisation, and have had to navigate the myriad of known and unknown challenges and opportunities that arise along the way.
My assumption on the most recent direction, as referenced in Steve's extract, is that because it's a new frontier, the way forward is not necessarily clear. They are now seeing the best chance of success is to broaden their scope and run concurrent smaller strategies with specialist industry partners.
The unknown potential of the tech and emerging applications have to be assessed as they become apparent, and then pivot on current plans to ensure the highest, best possible use is seized upon in order to establish the foundation of what can potentially be a very widely used treatment.
I like what they're doing, it means we are diversifying our approach!